Infect Chemother. 2009 Jul-Aug;41(4):216-223. Korean.
Published online Aug 31, 2009.
Copyright © 2009 The Korean Society of Infectious Diseases and The Korean Society for Chemotherapy
Original Article

Recent Trends of Anaerobic Bacteria Isolated from Clinical Specimens and Clinical Characteristics of Anaerobic Bacteremia

Yongjung Park, M.D.,1 Yangsoon Lee, M.D.,1 Myungsook Kim, M.S.,1 Jun Yong Choi, M.D.,2 Dongeun Yong, M.D.,1 Seok Hoon Jeong, M.D.,1 June Myung Kim, M.D.,2 Kyungwon Lee, M.D.,1 and Yunsop Chong, Ph.D.1
    • 1Department of Laboratory Medicine and Research Institute of Bacterial Resistance, College of Medicine, Yonsei University, Seoul, Korea.
    • 2Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, Korea.
Received April 23, 2009; Accepted August 10, 2009.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Anaerobic bacteria can cause various infections, and their incidence may differ greatly, depending on the country or hospital. We investigated recent trends in anaerobe isolation and clinical characteristics of anaerobic bacteremia in one hospital in Korea to facilitate diagnosis and treatment of anaerobic infections.

Materials and Methods

Anaerobic bacteria isolated from blood, body fluids and abscess specimens at a university hospital in Korea during 2007 and 2008 were analyzed. The medical records of 82 anaerobic bacteremia patients were reviewed. A retrospective cohort study was conducted to determine the risk factors for in-hospital mortality of patients with anaerobic bacteremia.

Results

A total of 289 non-duplicated anaerobic isolates were recovered from blood, body fluids and abscess specimens. Bacteroides fragilis (73 isolates, 25.3%) was the most common organism followed by Clostridium perfringens (22 isolates, 7.6%), Peptoniphilus asaccharolyticus (21 isolates, 7.3%) and Anaerococcus prevotii (19 isolates, 6.6%). Eighty-four isolates were recovered from blood specimens, among which B. fragilis (24 isolates) and C. perfringens (21 isolates) were the most frequently isolated organisms. Among the 196 underlying diseases of anaerobic bacteremia patients, neoplastic, infectious, and gastrointestinal diseases accounted for 54 (27.6%), 46 (23.5%), and 41 (20.9%) cases, respectively. The alimentary tract was the most common suspected portal of entry. The in-hospital mortality rate of anaerobic bacteremia patients was 34.2%, and neutropenia at the time of blood culture was the only statistically significant factor associated with mortality in this study. Anaerobes were isolated in 1.4% of all positive blood cultures.

Conclusions

B. fragilis and C. perfringens are expected to be commonly isolated from clinical specimens. Despite its low prevalence, anaerobic bacteremia displays a significant in-hospital mortality rate. Ongoing investigations into anaerobic bacteremia are necessary because of ambiguous risk factors for mortality.

Keywords
Anaerobe; Bacteremia; Bacteroides fragilis; Clostridium perfringens

Tables

Table 1
Distribution of Anaerobic Bacterial Strains Isolated from Various Clinical Specimens in a Single Korean Hospital in 2007 and 2008

Table 2
Site of infection and the Genus of Anaerobic Bacteria Isolated from the Blood

Table 3
Aerobic Bacteria Concomitantly Isolated with Anaerobes from the Blood

Table 4
Demographics and Factors Associated with In-hospital Mortality in 79 Patients with Anaerobic Bacteremia

References

    1. Finegold SM. Host factors predisposing to anaerobic infections. FEMS Immunol Med Microbiol 1993;6:159–163.
    1. Bishara J, Wattad M, Leibovici L, Samra Z, Lev B, Abramson E, Paul M. Predictors for anaerobic bacteraemia beyond the source of infection: retrospective, nested, case-control study. Scand J Infect Dis 2009;41:33–36.
    1. Lombardi DP, Engleberg NC. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med 1992;92:53–60.
    1. Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis 1996;23 Suppl 1:S97–S101.
    1. Arzese A, Trevisan R, Menozzi MG. The Italian Anaerobe Study Group. Anaerobe-induced bacteremia in Italy: a nationwide survey. Clin Infect Dis 1995;20 Suppl 2:230–232.
    1. Gómez J, Baños V, Ruiz J, Herrero F, Pérez M, Pretel L, Canteras M, Valdés M. Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992. Clin Investig 1993;71:595–599.
    1. Peraino VA, Cross SA, Goldstein EJ. Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis 1993;16 Suppl 4:288–291.
    1. Cockerill FR 3rd, Hughes JG, Vetter EA, Mueller RA, Weaver AL, Ilstrup DM, Rosenblatt JE, Wilson WR. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis 1997;24:403–418.
    1. Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE. Reemergence of anaerobic bacteremia. Clin Infect Dis 2007;44:895–900.
    1. Fenner L, Widmer AF, Straub C, Frei R. Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J Clin Microbiol 2008;46:2432–2434.
    1. Robert R, Deraignac A, Le Moal G, Ragot S, Grollier G. Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia. Eur J Clin Microbiol Infect Dis 2008;27:671–678.
    1. Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect 2006;12:527–532.
    1. Cheon SH, Kim JM, Kim E, Hong CS. Clinical analysis of bacteremia due to anaerobic organisms. Korean J Infect Dis 1989;21:87–94.
    1. Yoon JY, Choo EJ, Choi SH, Kim MN, Kim NJ, Kim YS, Woo JH, Ryu JS, Chang MS. Clinical characteristics and outcome of invasive Prevotella infection. Korean J Med 2003;64:254–259.
    1. Shin HJ, Kim MS, Lee K, Chong Y. Trends of Anaerobic Bacteria Isolated from Clinical Specimens. Korean J Clin Pathol 1999;19:70–77.
    1. Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. In: Wadsworth-KTL anaerobic bacteriology manual. 6th ed. Belmont: Star Publishing Company; 2002.
    1. Brook I, Frazier EH. Infections caused by Propionibacterium species. Rev Infect Dis 1991;13:819–822.
    1. Clinical and Laboratory Standards Institute. Principles and Procedures for Blood Cultures. Approved Guideline M47-A. Wayne, Pensylvania: Clinical and Laboratory Standards Institute; 2007. pp. 36.
    1. Wilson JR, Limaye AP. Risk factors for mortality in patients with anaerobic bacteremia. Eur J Clin Microbiol Infect Dis 2004;23:310–316.
    1. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
    1. Kiani D, Quinn EL, Burch KH, Madhavan T, Saravolatz LD, Neblett TR. The increasing importance of polymicrobial bacteremia. JAMA 1979;242:1044–1047.
    1. Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007;20:593–621.
    1. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. In: Manual of Clinical Microbiology. 9th ed. Washington DC: ASM Press; 2007. pp. 377.
    1. Lee KW, Chong YS, Park QE, Kim MS, Kwon OH. The effect of primary culture media on the isolation of anaerobic bacteria. J Lab Med Qual Assur 1994;16:111–116.
    1. Chung HK, Chong Y, Lee SY. Effect of brain heart infusion supplementation to Phenylethanol agar on the growth of anaerobic bacteria. Korean J Clin Pathol 1983;3:51–59.
    1. Bengualid V, Singh H, Singh V, Berger J. An increase in the incidence of anaerobic bacteremia: true for tertiary care referral centers but not for community hospitals? Clin Infect Dis 2008;46:323–324.
    1. Kim HO, Kang CG, Chong Y, Lee SY. Organisms isolated from blood at the Yonsei medical center, 1974-1983. Korean J Infect Dis 1985;17:15–32.
    1. Kim HK, Lee K, Chong Y, Kwon OH, Kim JM, Kim DS. Blood culture results at the Severance hospital during 1984-1993. Korean J Infect Dis 1996;28:151–165.
    1. Koh EM, Lee SG, Kim CK, Kim M, Yong D, Lee K, Kim JM, Kim DS, Chong Y. Microorganisms Isolated from Blood Cultures and Their Antimicrobial Susceptibility Patterns At a University Hospital During 1994-2003. Korean J Lab Med 2007;27:265–275.
    1. Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin Microbiol Infect 2005;11:724–729.
    1. Claros MC, Claros ZC, Hecht DW, Citron DM, Goldstein EJ, Silva J Jr, Tang-Feldman Y, Rodloff AC. Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates. Anaerobe 2006;12:17–22.
    1. Muttaiyah S, Paviour S, Buckwell L, Roberts SA. Anaerobic bacteraemia in patients admitted to Auckland City Hospital: its clinical significance. N Z Med J 2007;120:U2809.
    1. Fry DE. Preventive systemic antibiotics in colorectal surgery. Surg Infect (Larchmt) 2008;9:547–552.

Metrics
Share
Tables

1 / 4

PERMALINK